Lonza Group is a life sciences-oriented chemical and biotechnology company. Headquartered in Switzerland, it operates over 20 production plants and R&D centers worldwide.

Lonza is one of the leading global suppliers in the pharmaceutical, healthcare, and life sciences sectors, offering products and services that meet customer needs from research and development to final product manufacturing. Whether from a chemical or biotechnological perspective, Lonza is a world leader in the production and support of pharmaceutical active ingredients. Biopharmaceuticals are one of the major driving forces in the development of the pharmaceutical and biotechnology industries. Lonza's strengths also extend to small and large molecules, peptides, amino acids, and niche biologics, which play a critical role in the development of new drugs and healthcare products. In areas such as cell-based research, endotoxin testing, and cell therapy production, Lonza is also a leader. Additionally, Lonza provides valuable chemical and biotechnological ingredients for markets including nutrition, hygiene, preservation, agrochemicals, and personal care products.

Lonza will continue to advance science and technology, prioritizing advanced R&D centers and modern facilities and equipment to protect the environment and produce high-quality products. Innovative thinking, dedicated employees, and abundant resources are the advantages that support Lonza's long-term development.